Afshin Moradi on TSH Level and Stroke Severity
Afshin Moradi, Student and Researcher at Tabriz University of Medical Sciences, shared on LinkedIn:
”I’m pleased to share our recently published study exploring the relationship between thyroid-stimulating hormone (TSH) levels and stroke severity.
Key highlights:
• Stroke severity showed a significant inverse correlation with TSH levels during hospital admission and at discharge.
• Higher TSH levels were associated with less severe stroke symptoms in the acute phase.
• No significant association was found between TSH levels and stroke severity before admission or three months after discharge.
• TSH levels were not related to age, gender, stroke subtype, or CT findings.
These findings suggest a potential role of thyroid function in stroke severity, highlighting the need for further large-scale studies.”
Read the full article here.
Article: Association Between TSH Level and Stroke Severity: A Cross-Sectional Study Using the mRS
Authors: Afshin Moradi, Asal Ebrahimian, Seyed Ardalan Alhoseini, Kosar Baghernezhad, Amir Ghaffarzad, Sona Abolhasani, Vahideh Sadra, Samad Shams Vahdati
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership
-
Jul 10, 2026, 15:11Thirunavukkarasu Angappan: The Geopolitics of Plasma Supply and Self-Sufficiency
-
Jul 10, 2026, 14:51Danielle Boyle: Global Collaboration Takes Center Stage at ISTH 2026
-
Jul 10, 2026, 14:29Beril Awuor: The Functional Architecture of Blood and Its Physiological Significance
-
Jul 10, 2026, 14:15Arezoo Esteki: The Rising Role of Platelet-Rich Plasma in Precision Regenerative Care
-
Jul 10, 2026, 14:04Morgan Fogarty: A New Era of Continuous Bedside Brain Monitoring After Stroke
-
Jul 10, 2026, 13:50Nikki Veale: The Digital Stroke Recovery Programme in Cornwall Is Out Now
-
Jul 10, 2026, 13:43Fiona Bardon: Shaping Better Long-Term Stroke Care Through the CLASP Pathway
-
Jul 10, 2026, 13:22Rohan Arora: Can Artificial Intelligence Improve Informed Consent in Stroke Clinical Trials?